Skip to main content
. 2019 Oct 23;10:2040620719882822. doi: 10.1177/2040620719882822

Figure 2.

Figure 2.

Venetoclax dose ramp-up and tumor lysis syndrome preventive measures.

HMA, hypomethylating agents; IV, intravenously; LDAC, low-dose cytarabine; SC, subcutaneously; TLS, tumor lysis syndrome; VEN, venetoclax; WBC, white blood cell count.